SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SNRS- Sunrise Technologies
SNRS 0.00Jan 21 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Peter van Steennis who wrote (2841)7/25/1999 12:05:00 AM
From: Jacques Chitte  Read Replies (1) of 4140
 
>I am sure the panel felt "at risk" if they approved the procedure with
this knowledge. Imagine what an attorney would do to all of them if his clients eye sight was lost or further
impaired.<

That is sensible on the face of it, but there are some things that don't line up.
1) Visx would be liable in the same way as Snrs. Visx clearly doesn't always work. And Snrs has an extraordinary safety record.
2) The ODP panel was an unrelieved ambush. Snrs went in with the de facto reassurance that its application was in order. These things aren't like taking the SAT. there is dialog between the applicant and the agency.
Big money of some sort came in and rigged the game.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News